Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on "time in range" in patients with type 2 diabetes

• Main Authors: Yongru Chen (Author), Jingxian Chen (Author), Shuo Zhang (Author), Dan Zhu (Author), Feiying Deng (Author), Rui Zuo (Author), Yufei Hu (Author), Yue Zhao (Author), Yale Duan (Author), Benwei Lin (Author), Fengwu Chen (Author), Yun Liang (Author), Jiaxiong Zheng (Author), Barkat Ali Khan (Author), Kaijian Hou (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Diabetes affects millions of people worldwide annually, and several methods, including medications, are used for its management; glucagon-like peptide-1 receptor agonists (GLP-1RAs) are one such class of medications. The efficacy and safety of GLP-1RAs in treating type 2 diabetes mellitu...